Parallel Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.6K Buy
1,615
+542
+51% +$9.47K ﹤0.01% 2363
2025
Q4
$19.1K Buy
+1,073
New +$18.8K ﹤0.01% 2317
2025
Q2
Sell
-84
Closed -$2.07K 3637
2025
Q1
$2.07K Sell
84
-4
-5% -$99 ﹤0.01% 2968
2024
Q4
$2.04K Hold
88
﹤0.01% 2966
2024
Q3
$2.39K Hold
88
﹤0.01% 2846
2024
Q2
$2.53K Hold
88
﹤0.01% 2740
2024
Q1
$2.57K Sell
88
-28
-24% -$783 ﹤0.01% 2747
2023
Q4
$3.77K Buy
+116
New +$3.36K ﹤0.01% 2604
2021
Q4
Sell
-65
Closed -$4K 3189
2021
Q3
$4K Buy
+65
New +$4.22K ﹤0.01% 2461

Other funds holding KIDS

Parallel Advisors's KIDS Position: Q1 2026 in Review

Parallel Advisors increased its OrthoPediatrics (KIDS) stake by 51% in Q1 2026, buying an estimated $9.47K and bringing the position to 1,615 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

Parallel Advisors first reported a position in KIDS in Q3 2021 and has held it in 9 quarters since. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Parallel Advisors held 1,615 shares of OrthoPediatrics worth $25.6K as of Q1 2026.
  • Parallel Advisors bought 542 OrthoPediatrics shares in Q1 2026, an estimated $9.47K.
  • OrthoPediatrics made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2363 holding.
  • Parallel Advisors first reported a position in OrthoPediatrics in Q3 2021 and has held it in 9 quarters since.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.